In 1976 Japan expanded the scope of its patent law by extending coverage to newly-developed chemical and pharmaceutical products. Previously the patent law had only provided protection to new production processes for manufacturing chemicals and pharmaceuticals. We use rate of return data from the Tokyo Stock Exchange for Japanese pharmaceutical companies to determine whether these firms gained from the introduction of pharmaceutical product patents. Using two different methodologies we find that the stock price for a portfolio of pharmaceutical firms and for individual firms significantly increased in response to the passage of the 1975 patent law.
Download Info
To download:
If you experience problems downloading a file, check if you have the
proper application to
view it first. Information about this may be contained
in the File-Format links below. In case of further problems read
the IDEAS help
page. Note that these files are not on the IDEAS
site. Please be patient as the files may be large.
Publisher Info
Paper provided by University of Hawaii at Manoa, Department of Economics in its series Working Papers with number
199201.
References listed on IDEAS Please report citation or reference errors to , or , if you are the registered author of the cited work, log in to your RePEc Author Service profile, click on "citations" and make appropriate adjustments.:
Cited by: (explanations, Please report citation or reference errors to , or , if you are the registered author of the cited work, log in to your RePEc Author Service profile, click on "citations" and make appropriate adjustments.)